Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.

van Besien K, Devine S, Wickrema A, Jessop E, Amin K, Yassine M, Maynard V, Stock W, Peace D, Ravandi F, Chen YH, Cheung T, Vijayakumar S, Hoffman R, Sosman J
Bone Marrow Transplant. 2003 32 (1): 9-13

PMID: 12815472 · DOI:10.1038/sj.bmt.1704088

MeSH Terms (21)

Adolescent Adult Antineoplastic Agents, Alkylating Child Combined Modality Therapy Graft Survival Graft vs Host Disease Haplotypes Hematologic Neoplasms Histocompatibility Humans Middle Aged Peripheral Blood Stem Cell Transplantation Survival Analysis Thiotepa Transplantation, Homologous Transplantation Conditioning Treatment Failure Treatment Outcome Vidarabine Whole-Body Irradiation

Connections (1)

This publication is referenced by other Labnodes entities: